FOLFOX Chemotherapy: Efficacy and Tolerability in Advanced Digestive Neuroendocrine Neoplasms (NENs)
Introduction: FOLFOX has been poorly investigated in digestive NEN (DNENs), mostly in small cohorts.
Aim(s): To analyze efficacy, predictive factors of response and tolerability of FOLFOX in a consecutive series of advanced DNENs.
Materials and methods: Retrospective analysis of patients (pts) receiving FOLFOX IV in 2005-2015, with at least 3-mos follow-up. Objective response (OR) and progression-free survival (PFS) were assessed; prognostic factors analyzed by Cox-regression model.
Conference: 13th Annual ENETSConcerence (2016)
To read the full abstract, please log into your ENETS Member account.